MediSolution Ltd.
TSX : MSH

MediSolution Ltd.

December 12, 2007 08:30 ET

DaVita Laboratories Implement MediSolution's Virtuo Revenue Cycle Management Solution

MONTREAL, QUEBEC--(Marketwire - Dec. 11, 2007) - MediSolution Ltd (TSX:MSH) today announced the implementation Go-Live of the Virtuo® Revenue Cycle Management (RCM) solution at DaVita Laboratories, wholly owned subsidiaries of DaVita, Inc., one of the leading providers of kidney care services in the United States. The comprehensive revenue cycle management system was selected to fill the complex billing and accounts receivable requirements within DaVita's laboratory services group.

DaVita Laboratories supply services in support of DaVita, Inc. As the largest independent provider of dialysis services in the United States, DaVita provides dialysis services for those diagnosed with chronic kidney failure. With over 1,300 outpatient dialysis facilities and acute units in 700 hospitals, DaVita serves over 103,000 patients located in 43 states and the District of Columbia.

DaVita Laboratories was faced with merging multiple billing and accounts receivable systems onto one platform. The new solution was required to interface to three separate patient registration systems, a corporate physician information system, a corporate ordering system and a laboratory system.

"We required a scalable billing system that could handle our high volume and complex billing requirements," said Jason Kotar, Director of Patient Accounting for DaVita Laboratories. "MediSolution handily met the challenge, providing us with excellent support throughout the implementation process and a system that was delivered on time and within budget."

Virtuo RCM's customizable, rules-based workflow engine provided DaVita's laboratories with the ability to configure the system to accommodate the complex laboratory renal dialysis billing requirements including Correct Coding Initiative (CCI) and National Coverage Decisions (NCD's). The comprehensive solution also reduces the amount of staff intervention required through a series of automated pre-billing edits that scrub claims for errors prior to submission.

"The Virtuo Revenue Cycle Management system's flexible open architecture and customizable workflow engine make it a logical choice for laboratories with unique billing needs", said Paul Lepage, President and Chief Executive Officer of MediSolution. "The adaptable solution can be easily integrated with most IT systems from a multitude of vendors."

About MediSolution

MediSolution (TSX:MSH), a Brookfield Asset Management company, is a leading healthcare and public sector information technology company, providing software, solutions and services to customers across North America. More than 500 hospitals and other healthcare facilities and close to 200 public sector and related organizations rely on MediSolution's systems to maximize their operational efficiencies, lower their costs, and improve the delivery of services. MediSolution has two operating segments. The Resource Management Systems segment is comprised of Financial Management software such as accounts receivable, budgeting and materials management as well as Human Capital Management tools including human resource management, staff scheduling and payroll processing. The Healthcare Information Systems segment is comprised of clinical solutions such as patient tracking, electronic patient health records, pharmacy, radiology and laboratory software for healthcare organizations.

About DaVita, Inc.

DaVita, Inc., a FORTUNE 500® company, is a leading provider of dialysis services in the United States, providing dialysis services for patients with chronic kidney failure and end stage renal disease. DaVita manages over 1,300 outpatient facilities and acute units in over 700 hospitals located in 43 states and the District of Columbia, serving more than 103,000 patients. For more information please visit http://www.davita.com.

This press release contains "forward-looking statements" regarding MediSolution's Virtuo RCM solution and its contract with DaVita Laboratories. The words "believe", "expect", "anticipate", "intend", "estimate" and other expressions which are predictions of or indicate future events and trends and which do not relate to historical matters identify forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements because they involve known an unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company to differ materially from anticipated future results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those set forth in the forward-looking statements include failure to secure customer interest in the Virtuo RCM 3.0 solution, the cancellation of the Virtuo RCM contract with DaVita Laboratories and the financial management product's failure to generate anticipated business efficiencies and value for the client.

Contact Information